RxDoctor Payments DataLook up a doctor →

Matthew Wenker

Internal Medicine · Erlanger, KYNPI 1760472617

Payments from drug & device makers

$12,844,211in general payments, 2019–2025

Across 5,113 payments — averaging $2512.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Modernatx, Inc.$9.3M
  • Seqirus USA Inc$810K
  • Boehringer Ingelheim$677K
  • AstraZeneca$667K
  • Eli Lilly$516K
  • Regeneron$330K
  • plus $571K from 22 others
$22,870in research payments, 2019–2025

Across 28 payments — averaging $816.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$18K
  • Corcept Therapeutics$2K
  • Novavax Inc$1K
  • Regeneron$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,844,211 in reported general payments places this provider in the 95th percentile of 1,284 internal medicine providers in Kentucky.

See all internal medicine providers in Kentucky

Other internal medicine in Erlanger

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →